Germany · Delayed Price · Currency is EUR Pentixapharm Holding AG Statistics
Total Valuation
FRA:PTP has a market cap or net worth of EUR 36.33 million. The enterprise value is 29.36 million.
| Market Cap | 36.33M |
| Enterprise Value | 29.36M |
Important Dates
The last earnings date was Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
| Current Share Class | 24.78M |
| Shares Outstanding | n/a |
| Shares Change (YoY) | +99.69% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 0.20% |
| Owned by Institutions (%) | 7.67% |
| Float | 15.24M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 23.91 |
| PB Ratio | 0.99 |
| P/TBV Ratio | 10.30 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -1.11 |
| EV / Sales | 19.32 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -1.25 |
Financial Position
The company has a current ratio of 3.48
| Current Ratio | 3.48 |
| Quick Ratio | 2.76 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -204.50 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | n/a |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | -50.67% |
| Revenue Per Employee | 23,742 |
| Profits Per Employee | -414,031 |
| Employee Count | 75 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -3.81M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -51.13% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -51.13% |
| 50-Day Moving Average | 1.58 |
| 200-Day Moving Average | 2.28 |
| Relative Strength Index (RSI) | 42.87 |
| Average Volume (20 Days) | 110 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, FRA:PTP had revenue of EUR 1.52 million and -26.50 million in losses. Loss per share was -0.61.
| Revenue | 1.52M |
| Gross Profit | -6.94M |
| Operating Income | -20.45M |
| Pretax Income | -30.31M |
| Net Income | -26.50M |
| EBITDA | -17.68M |
| EBIT | -20.45M |
| Loss Per Share | -0.61 |
Balance Sheet
The company has 6.97 million in cash and n/a in debt, giving a net cash position of 6.97 million.
| Cash & Cash Equivalents | 6.97M |
| Total Debt | n/a |
| Net Cash | 6.97M |
| Net Cash Per Share | n/a |
| Equity (Book Value) | 36.72M |
| Book Value Per Share | 1.48 |
| Working Capital | 6.44M |
Cash Flow
In the last 12 months, operating cash flow was -22.32 million and capital expenditures -1.24 million, giving a free cash flow of -23.56 million.
| Operating Cash Flow | -22.32M |
| Capital Expenditures | -1.24M |
| Free Cash Flow | -23.56M |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,345.84% |
| Pretax Margin | -1,994.47% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FRA:PTP does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -99.69% |
| Shareholder Yield | -99.69% |
| Earnings Yield | -72.93% |
| FCF Yield | -64.84% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
FRA:PTP has an Altman Z-Score of 4.48 and a Piotroski F-Score of 2.
| Altman Z-Score | 4.48 |
| Piotroski F-Score | 2 |